FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

424725004: Agalsidase beta (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3688105010 Agalsidase beta (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3688106011 Agalsidase beta en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2640333019 Recombinant agalsidase beta (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2640333019 Recombinant agalsidase beta (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2644388014 Recombinant agalsidase beta en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2644388014 Recombinant agalsidase beta en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3688105010 Agalsidase beta (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3688106011 Agalsidase beta en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
53581000195115 agalsidasi beta it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
68491000195118 Agalsidase beta de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
523901000188114 agalsidase bêta fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
523901000188114 agalsidase bêta fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
53581000195115 agalsidasi beta it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
68491000195118 Agalsidase beta de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Agalsidase beta Is a Alpha-galactosidase false Inferred relationship Existential restriction modifier (core metadata concept)
Agalsidase beta Has disposition Hydrolase true Inferred relationship Existential restriction modifier (core metadata concept)
Agalsidase beta Is a Galactosidase true Inferred relationship Existential restriction modifier (core metadata concept)
Agalsidase beta Is a Recombinant protein (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Agalsidase beta 5 mg powder for solution for injection vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Agalsidase beta Inferred relationship Existential restriction modifier (core metadata concept)
Agalsidase beta 35 mg powder for solution for injection vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Agalsidase beta Inferred relationship Existential restriction modifier (core metadata concept)
Agalsidase beta-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Agalsidase beta Inferred relationship Existential restriction modifier (core metadata concept) 1
Agalsidase beta 5 mg powder for solution for injection vial Has basis of strength substance (attribute) True Agalsidase beta Inferred relationship Existential restriction modifier (core metadata concept) 1
Agalsidase beta 5 mg powder for solution for injection vial Has precise active ingredient True Agalsidase beta Inferred relationship Existential restriction modifier (core metadata concept) 1
Agalsidase beta 35 mg powder for solution for injection vial Has precise active ingredient True Agalsidase beta Inferred relationship Existential restriction modifier (core metadata concept) 1
Agalsidase beta 35 mg powder for solution for injection vial Has basis of strength substance (attribute) True Agalsidase beta Inferred relationship Existential restriction modifier (core metadata concept) 1
Agalsidase beta-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Agalsidase beta Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only agalsidase beta (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Agalsidase beta Inferred relationship Existential restriction modifier (core metadata concept) 1
Agalsidase beta only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Agalsidase beta Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start